GP40221 (semaglutide biosimilar)
/ Geropharm
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 11, 2024
Open Randomized Study of Comparative Pharmacokinetics and Biosimilarity of GP40221 (GEROPHARM LLC, Russia) and Ozempic®.
(clinicaltrials.gov)
- P1 | N=120 | Completed | Sponsor: Geropharm
New P1 trial
1 to 1
Of
1
Go to page
1